LUIZ FERNANDO LOPES SILVA1,#, JULIETE NATHALI SCHOLL1,#, AUGUSTO FERREIRA WEBER1, CAMILA KEHL DIAS1, PAULINE RAFAELA PIZZATO2, VINíCIUS PIERDONá LIMA1, JEAN SÉVIGNY3,4, ANA MARIA OLIVEIRA BATTASTINI1, FABRÍCIO FIGUEIRÓ1,2,*
Oncology Research, Vol.33, No.4, pp. 951-964, 2025, DOI:10.32604/or.2024.055508
- 19 March 2025
Abstract Objectives: Glioblastoma (GB) is a grade IV glial tumor characterized by high malignancy and dismal prognosis, primarily due to high recurrence rates and therapeutic resistance. The epidermal growth factor receptor (EGFR), a receptor tyrosine kinase (RTK), regulates signaling pathways, including cell growth, proliferation, survival, migration, and cell death. Many cancers utilize immune checkpoints (ICs) to attenuate immune responses. CD73 is an enzyme that functions as an IC by hydrolyzing AMP to adenosine, suppressing immune cells in the tumor microenvironment. However, the role of CD73 in resistance to EGFR inhibitors is poorly understood. This study aims… More >